Schedule II-Condensed Financial Information of Registrant - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Condensed Financial Statements, Captions [Line Items]
Due from subsidiaries	$ 6,307	$ 6,016
Due to subsidiaries	(10,255)	(10,029)
Elevance Health, Inc.
Condensed Financial Statements, Captions [Line Items]
Cash dividends received from subsidiaries	2,543	6,322	$ 4,909
Cash dividends paid to subsidiaries	82	78	71
Capital contribution to subsidiaries	1,567	324	$ 363
Due from subsidiaries	99	49
Parental guarantees	819	912
Elevance Health, Inc. | Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Due from subsidiaries	$ 208	4,697
Due to subsidiaries		$ 4,697